SCHEMBL5169618

SCHEMBL5169618

O=[N+]([O-])c1cccc(-c2cc(N3CCOCC3)ncn2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.56
DPP4 P27487 1/20 0.56
ALDH1A1 P00352 4/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPK1 P28482 2/20 0.52
RAB9A P51151 8/20 0.52
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
HPGD P15428 1/20 0.51
NPC1 O15118 7/20 0.48
TDP1 Q9NUW8 1/20 0.48
TSHR P16473 1/20 0.47
RECQL P46063 1/20 0.47
LRRK2 Q5S007 1/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MGLL Q99685 1/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1263673 0.81 MAPK1 (0.53) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL4934505 0.79 TSHR (0.52) SMN1; SMN2MAPK1RAB9ANPC1TSHR
SCHEMBL27319619 0.78 SMN1; SMN2 (0.63) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1
Hydrochloric Acid SCHEMBL11787337 0.78 NPC1 (0.70) SMN1; SMN2DPP4ALDH1A1MAPK1RAB9A
SCHEMBL28054609 0.77 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL4937750 0.76 PIK3CA (0.59) ALDH1A1MEN1KMT2AMAPK1RAB9A
SCHEMBL4603940 0.76 PIK3CA (0.59) ALDH1A1MEN1KMT2AMAPK1RAB9A
SCHEMBL30619358 0.75 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL248354 0.75 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL1442621 0.75 MEN1 (0.53) SMN1; SMN2ALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773824-A1 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER AstraZeneca AB (SE) 2007-04-18 EP disclosed
WO-2006005915-A1 2, 4, 6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2006-01-19 WO disclosed